Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly.
Evodiamine Attenuates Experimental Colitis Injury Via Activating Autophagy and Inhibiting NLRP3 Inflammasome Assembly.
复制标题
吴茱萸碱通过激活自噬和抑制 NLRP3 炎症小体组装减轻实验性结肠炎损伤。
DOI:
10.3389/fphar.2020.573870
复制
发表时间:
2020
影响因子:
5.6
通讯作者:
Du R
中科院分区:
文献类型:
--
作者:
Ding W;Ding Z;Wang Y;Zhu Y;Gao Q;Cao W;Du R
Autophagy and NLRP3 inflammasome were associated with the process of colitis. Drugs targeting NLRP3 inflammasome and autophagy to treat colitis are absent, and they are urgently required. Herein, we examine the effect of evodiamine, extracted from the fruit of Evodiae Fructus, on experimental colitis induced by dextran sulfate sodium and exposit whether evodiamine effects on autophagy and NLRP3 inflammasome. Our data indicated that colitis was ameliorated by evodiamine, including the improvement of mice body weight, colon length, histopathologic score, and the disease activity index. We also observed that evodiamine restrained the formation of the NLRP3 inflammasome by inhibiting the apoptosis-associated speck-like protein oligomerization and caspase-1 activity in THP-1 macrophages. Our results demonstrated evodiamine inhibit NLRP3 inflammasome activation via the induction of autophagosome-mediated degradation of inflammasome and the inhibition of NFκB pathway, which synergistically contribute to the effect of evodiamine in colitis. It indicates the potential use of evodiamine in inflammatory bowel diseases treatment.
登录
查看更多内容
影响因子:
29.7
作者:
Davis BK;Wen H;Ting JP
通讯作者:
Ting JP
DOI:
10.4049/jimmunol.0802367
发表时间:
2009-03-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Bryan NB;Dorfleutner A;Rojanasakul Y;Stehlik C
通讯作者:
Stehlik C
影响因子:
16
作者:
Ganley IG;Wong PM;Gammoh N;Jiang X
通讯作者:
Jiang X
影响因子:
7.3
作者:
Chen L;You Q;Hu L;Gao J;Meng Q;Liu W;Wu X;Xu Q
通讯作者:
Xu Q
影响因子:
3.4
作者:
Ge X;Chen SY;Liu M;Liang TM;Liu C
通讯作者:
Liu C